PRA International Recognized at Clinical Excellence Awards

RALEIGH, North Carolina -

Most Successful Early Phase Trial - PRA International, a leading Clinical Research Organization, is pleased to announce that a study it has been conducting for one of its customers was awarded the “Most Successful Early Phase Trial” at the 2009 Good Clinical Practice Journal’s (GCPj) Clinical Research Excellence Awards in London. The GCPj Awards recognize and reward corporate and individual excellence in clinical research, involving partnerships between sponsors, CROs and investigators. The study selected to win the award this year is one that PRA conducted as a Phase I study of a novel anti-thrombotic drug for Belgian biopharmaceutical company Ablynx.

“We are very proud to have collaborated with Ablynx on this study,” commented Christa Raab, Director of Project Delivery for PRA. “Using biomarkers and PK/PD modeling for the study, the PRA project team, which included members from our Bioanalytical Laboratory in Assen, The Netherlands, worked closely with Ablynx.”

About PRA International

PRA International conducts clinical trials in more than 65 countries across 6 continents and provides services through all phases of clinical development. PRA performs studies in all therapeutic areas, with specialization in Oncology, Neurosciences, Respiratory/Allergy, Cardiovascular and Infectious Diseases. PRA has supported over 2,100 clinical trials through its 36 global offices. PRA supports numerous trials across various phases with its bioanalytical lab in Assen, The Netherlands.

PRA’s therapeutic expertise, global reach and project experience, combined with extensive local knowledge and our differentiating PERSONAL ELEMENT enable our project teams to deliver consistent and on time performance for our clients. This unique PRA philosophy - THE PERSONAL ELEMENT - recognizes that true client service comes only from trained, empowered and dedicated employees who are encouraged to use innovation and their personal commitment to accelerate the development lifecycle.

To learn more about PRA International, please visit www.PRAinternational.com, email Endpoints@PRAintl.com or call our Global Headquarters at +1-919-786-8200.

Source: PRA International

Roger Boutin, Director of Marketing of PRA International, Inc., +1-434-951-3924